Products

Primary tabs

Export products to Excel

Displaying 91 - 105 of 207
Alternative Name: Pericoital LNG gel
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Gel
Project Stage: Phase I
Alternative Name: Smaller/Nulliparous Copper IUD
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Alternative Name: Leukemia inhibitory factor (LIF) and interleukin-11 (IL-11)
Development Status: Inactive
Target: Female
Mode: Non-hormonal
Project Stage: Target ID/Validation
Alternative Name: Levosert (U.K.), Erlacela (Portugal), Donasert (Romania)
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Partner: Actavis, Medicines360
Alternative Name: Twirla, AG200-15, Levonorgestrel + ethinyl estradiol patch
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase III
Development Status: Active Development
Target: Female, Male
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase I
Partner: WHO HRP, CONRAD, NICHD
Alternative Name: Levonorgestrel (LNG) Intracervical Device (ICD)
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Vaginal, Other
Project Stage: Phase I
Alternative Name: Levonorgestrel (LNG)-only patch; AG890
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase I
Alternative Name: One-year LNG Single Rod Implant
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Phase I
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Pre-clinical
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Injectable, Subdermal
Project Stage: Pre-clinical
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase I
Partner: FHI 360
Alternative Name: Medicated Contraceptive Ring-165
Development Status: Limited Market Approval
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Phase II
Partner: Merck
Export to Excel